Specificity of a circulating antibody that interferes with a widely used tacrolimus immunoassay

Therapeutic Drug Monitoring

Volumn 32, Issue 2, 2010, Pages 228-231

  Parikh, Bijal A ^a   Siedlecki, Andrew M ^b   Scott, Mitchell G ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

Immunoassay; Interference; Tacrolimus

Indexed keywords

ANTIBODY; BETA GALACTOSIDASE; EPITOPE; TACROLIMUS;

ACCURACY; ADULT; ARTICLE; CASE REPORT; CONJUGATE; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; EVENING DOSAGE; HUMAN; IMMUNOADSORPTION; IMMUNOASSAY; KIDNEY GRAFT; MALE; PRIORITY JOURNAL; RECIPIENT; BINDING COMPETITION; BLOOD; IMMUNOLOGY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; PHARMACEUTICS; PROCEDURES; STANDARDS;

ADULT; ANTIBODIES; BINDING, COMPETITIVE; HUMANS; IMMUNOASSAY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; TACROLIMUS; TECHNOLOGY, PHARMACEUTICAL;

EID: 77950201541     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e3181d4e7a9     Document Type: Article

References (15)

1. Taylor AL, Watson CJ, Bradley JA. Immunosuppressive agents in solid organ transplantation: mechanisms of action and therapeutic efficacy. Crit Rev Oncol Hematol. 2005;56:23-46.
2. Emmett M, Narins RG. Clinical use of the anion gap. Medicine (Baltimore). 1977;56:38-54.
3. Robertson GL. Diabetes insipidus. Endocrinol Metab Clin North Am. 1995;24:549-572.
4. Gaston RS. Maintenance immunosuppression in the renal transplant recipient: an overview. Am J Kidney Dis. 2001;38:S25-S35.
5. Kricka LJ. Human anti-animal antibody interferences in immunological assays. Clin Chem. 1999;45:942-956.
6. Kricka LJ, Schmerfeld-Pruss D, Senior M, et al. Interference by human anti-mouse antibody in two-site immunoassays. Clin Chem. 1990;36: 892-894.
7. Tacrolimus[Package Insert]. Newark, DE: Dade Behring Inc; 2007.
8. Tamura K, Kobayashi M, Hashimoto K, et al. A highly sensitive method to assay FK-506 levels in plasma. Transplant Proc. 1987;19:23-29.
9. Boorsma DM, Kalsbeek GL. A comparative study of horseradish peroxidase conjugates prepared with a one-step and a two-step method. J Histochem Cytochem. 1975;23:200-207.
10. O'Sullivan MJ, Gnemmi E, Morris D, et al. A simple method for the preparation of enzyme-antibody conjugates. FEBS Lett. 1978;95: 311-313.
11. Kim WJ, Laterza OF, Hock KG, et al. Performance of a revised cardiac troponin method that minimizes interferences from heterophilic antibodies. Clin Chem. 2002;48:1028-1034.
12. Altinier S, Varagnolo M, Zaninotto M, et al. Heterophilic antibody interference in a non-endogenous molecule assay: an apparent elevation in the tacrolimus concentration. Clin Chim Acta. 2009;402:193-195.
13. Rostaing L, Cointault O, Marquet P, et al. Falsely elevated whole-blood tacrolimus concentrations in a kidney-transplant patient: potential hazards. Transpl Int. 2009 Sep 15. [Epub ahead of print] doi:10.1111/ j.1432-2277.2009.00965.x.
14. Hermida J, Tutor JC. Falsely increased blood tacrolimus concentrations using the ACMIA assay due to circulating endogenous antibodies in a liver transplant recipient: a tentative approach to obtaining reliable results. Ther Drug Monit. 2009;31:269-272.
15. Wallemacq PE, Leal T, Besse T, et al. IMx tacrolimus II vs IMx tacrolimus microparticle enzyme immunoassay evaluated in renal and hepatic transplant patients. Clin Chem. 1997;43:1989-1991.